Costume 发表于 2025-3-26 21:27:29

http://reply.papertrans.cn/71/7002/700133/700133_31.png

不断的变动 发表于 2025-3-27 05:03:50

NAFLD Related-HCC: The Relationship with Metabolic Disorders,elopment. We also discussed the prevention options of NAFLD-HCC in view of obesity and metabolic disorder. These studies have extended our knowledge on the complicated mechanism of NAFLD and HCC, and provided the prevention options of NAFLD-HCC in patients with obesity and metabolic diseases.

miracle 发表于 2025-3-27 06:19:56

http://reply.papertrans.cn/71/7002/700133/700133_33.png

Headstrong 发表于 2025-3-27 11:28:21

Dysregulated Epigenetic Modifications in the Pathogenesis of NAFLD-HCC,n the pathogenesis of NAFLD-HCC. On the basis of currently wealthy knowledge of DNA epigenetics, the rapidly growing field of RNA epigenetics will certainly drive forward a new avenue of research direction shedding light on the advancement of better diagnostics, prognostics and therapeutics in the coming era of precision medicine.

清醒 发表于 2025-3-27 14:01:51

http://reply.papertrans.cn/71/7002/700133/700133_35.png

柏树 发表于 2025-3-27 20:20:23

Introduction,nd more than a third of them are obese. In addition to the well-publicized association of obesity with type II diabetes and cardiovascular diseases, emerging evidence indicates that obesity represents a major risk factor for fatty liver diseases and fatty liver disease-associated hepatocellular carcinoma (HCC).

gastritis 发表于 2025-3-28 00:23:14

Microbiota, Obesity and NAFLD, largely unknown, changes in intestinal inflammation, gut permeability, energy harvest, anaerobic fermentation and insulin resistance have been described. In this chapter, we review the relationship between the gut microbiota, obesity and NAFLD, and highlight potential ways to modify the gut microbiota to help managing NAFLD patients.

Supplement 发表于 2025-3-28 03:55:53

Book 2018ors are leading experts in the field. It will appeal to researchers, clinicians and graduate students in obesity, fatty liver diseases, GI/Liver cancer field. It may also yield benefits for pharmaceutical companies with regard to drug discovery..

fibula 发表于 2025-3-28 08:03:20

http://reply.papertrans.cn/71/7002/700133/700133_39.png

Colonnade 发表于 2025-3-28 12:55:19

0065-2598 nt topics in the field all together under one umbrella.Provi.This volume covers a state-of-the-art illustration of recent discoveries concerning obesity-related fatty liver diseases and liver cancer. The contents are extensive and comprehensive. It brings important topics in the field all together u
页: 1 2 3 [4] 5
查看完整版本: Titlebook: Obesity, Fatty Liver and Liver Cancer; Jun Yu Book 2018 Springer Nature Singapore Pte Ltd. 2018 non-alcoholic fatty liver disease (NAFLD).